Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Antiviral Therapy|August 24, 2012
Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant womenAurélie Fayet-Mello, Thierry Buclin, Nicole Guignard, et al.
Plos One|December 3, 2020
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medicationLuis Alameda, Axel Levier, Mehdi Gholam-Rezaee, et al.
The Pharmacogenomics Journal|December 29, 2017
Genetic and clinic predictors of new onset diabetes mellitus after transplantationNúria Saigi-Morgui, Lina Quteineh, Pierre-Yves Bochud, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatmentFrederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saigí-Morgui, et al.
British Journal of Clinical Pharmacology|January 18, 2014
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearanceMuriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Brain dopamine response in human opioid addictionMark R C Daglish, Tim M Williams, Sue J Wilson, et al.
European Journal of Nutrition|May 4, 2024
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studiesNermine Laaboub, Setareh Ranjbar, Marie-Pierre F Strippoli, et al.
Translational Psychiatry|July 6, 2021
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Antiviral Therapy|August 24, 2012
Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant womenAurélie Fayet-Mello, Thierry Buclin, Nicole Guignard, et al.
Plos One|December 3, 2020
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medicationLuis Alameda, Axel Levier, Mehdi Gholam-Rezaee, et al.
The Pharmacogenomics Journal|December 29, 2017
Genetic and clinic predictors of new onset diabetes mellitus after transplantationNúria Saigi-Morgui, Lina Quteineh, Pierre-Yves Bochud, et al.
The Journal of Clinical Psychiatry|December 10, 2015
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatmentFrederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saigí-Morgui, et al.
British Journal of Clinical Pharmacology|January 18, 2014
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearanceMuriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Brain dopamine response in human opioid addictionMark R C Daglish, Tim M Williams, Sue J Wilson, et al.
European Journal of Nutrition|May 4, 2024
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studiesNermine Laaboub, Setareh Ranjbar, Marie-Pierre F Strippoli, et al.
Translational Psychiatry|July 6, 2021
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Pageof 18